3 min read · 04 Dec 2025

Adenosine Monophosphate by Damien Hirst sold for $349,400. Image courtesy of Phillips
A work by Damien Hirst was the headline sale at Phillips 'New Now: Modern & Contemporary Art' auction on December 3 in London.


The star lot was: Damien Hirst, Adenosine Monophosphate (2012), which sold for $349,400, 33% above its $262,700 low estimate. It has not been traded before.

The outperformer sold for 463% above its low estimate. Luke Silva, Coimbra Fire (2023), sold for $44,300 ($7,865 low estimate). It has been traded once in the past.

Breakdown of results against auction house estimates that are disclosed
No sales had a guarantee.
32 works were bought-in, including: Sigmar Polke, Untitled (1999), estimated at $327,700 (low) to $458,800 (high). It has been traded twice in the past.
1 work was withdrawn before the sale: Taryn Simon, Folder: Explosions (2012) estimated at $10,500 (low) to $15,700 (high).
All results include the fees and premiums added to the price of a work of art when the auctioneer's hammer falls. Estimates, sale prices and totals are converted into US dollars. Sale prices are compared to the auction house’s low estimate, which do not include premiums.
Guarantees: Sometimes an auction house guarantees to pay a seller for a work, regardless of whether the bidding reaches the reserve price, a figure that is typically confidential.
Bought-in: If there are no bids for a work, or if bidding falls short of the reserve price, the lot is unsold or “bought-in”.
Withdrawn: This happens when a seller decides, for whatever reason, to withdraw a work before the bidding begins.
Premiums: Typically a sliding-scale of charges paid in addition to the hammer price by the buyer, plus any other fees.
Get the HENI News Daily Art Digest delivered to your inbox